## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and scope as presented in the abstract; no access to full text, figures, tables, or references
- **Shared manuscript claim summary** The abstract presents a review of machine learning (ML) and data mining (DM) methods applied to high-throughput next generation sequencing (NGS) data, covering unsupervised and supervised learning, dimensionality reduction, deep neural networks, and applications in bioinformatics. Specific areas include single-cell RNA sequencing (scRNA-seq) analysis, transcription factor binding sites, chromatin organization, RNA binding proteins, RNA sequence and structure, 3D protein structure prediction, and clinical oncology with pharmacogenomics for personalized treatments.
- **Visible evidence base** Abstract text only; no figures, tables, or reference list provided
- **Missing materials affecting confidence** Full manuscript text, figures, tables, reference list, and any supplementary materials are not available. The abstract lacks specific methodological details, quantitative results, and comparative evaluations, limiting the ability to assess technical depth and accuracy.

## Reviewer
- **Overall assessment** The abstract outlines a broad and ambitious review of ML and DM applications in NGS-based genomics and disease research. The scope is timely and relevant, given the rapid integration of AI in genomics. However, the abstract is largely descriptive and lacks critical evaluation, specific examples with outcomes, or a clear synthesis of challenges and future directions. The absence of full text prevents verification of the depth and accuracy of the claimed coverage. The review may serve as a useful introductory resource, but its scientific impact is not established from the abstract alone.
- **Who would be interested in the results, and why** Researchers and clinicians in bioinformatics, computational biology, genomics, and oncology would find this review useful as a broad overview of ML tools for NGS data. It may also appeal to data scientists seeking entry points into biological applications and to educators designing courses on AI in genomics. The clinical oncology and pharmacogenomics sections could interest translational researchers focused on personalized medicine.
- **Major strengths** The abstract covers a wide range of relevant topics, from fundamental ML principles to advanced applications like scRNA-seq and protein structure prediction. The inclusion of clinical oncology and pharmacogenomics adds translational relevance. The stated goal of bridging ML with genomics to understand disease mechanisms is commendable and aligns with current research priorities.
- **Major Concerns**  
  - **Concern ID** R1-M1  
    **Severity** Major  
    **Blocking** Yes  
    **Axis** Technical soundness  
    **Claim pointer** The abstract claims to provide "a thorough investigation of main novel ML applications" in genomics, including specific methods for scRNA-seq, TF binding, chromatin, RBPs, RNA structure, and protein structure prediction.  
    **Evidence pointer** Abstract text; location not provided  
    **Concern** The abstract does not provide any specific methodological details, performance metrics, or comparative analyses to substantiate the claim of thoroughness. It lists topics but offers no critical assessment of the strengths, limitations, or reproducibility of the discussed methods.  
    **Why it matters** A review's value lies in its critical synthesis and guidance for readers. Without evidence of depth, such as case studies with quantitative outcomes or discussion of pitfalls, the claim of thorough investigation is unsupported.  
    **Resolution test** Provide in the full text detailed examples with specific datasets, evaluation metrics, and comparisons across methods, and explicitly discuss limitations and open challenges for each application area.  
  - **Concern ID** R1-M2  
    **Severity** Major  
    **Blocking** Yes  
    **Axis** Scientific importance  
    **Claim pointer** The abstract implies that the reviewed ML methods "unravel the fundamental mechanisms of biology towards the understanding and cure of diseases."  
    **Evidence pointer** Abstract text; location not provided  
    **Concern** This is an overstatement. The abstract does not present any concrete examples where ML-driven NGS analysis has led to mechanistic biological insights or clinical breakthroughs. The causal link between ML applications and disease understanding is asserted, not demonstrated.  
    **Why it matters** Overclaiming impact can mislead readers, especially clinicians and funders, about the maturity of ML in genomics. A balanced review should acknowledge current limitations and the gap between computational predictions and validated biological mechanisms.  
    **Resolution test** In the full text, include case studies where ML predictions were experimentally validated or led to actionable clinical decisions, and explicitly state where such validation is lacking.  
  - **Concern ID** R1-M3  
    **Severity** Major  
    **Blocking** No  
    **Axis** Readability for nonspecialists  
    **Claim pointer** The abstract states it provides "an introduction to the basic mathematical principles" of ML methods.  
    **Evidence pointer** Abstract text; location not provided  
    **Concern** The abstract does not indicate the level of mathematical detail or the target audience. If the review aims to be accessible to biologists, the mathematical treatment must be carefully scaffolded. Conversely, if it targets computational readers, the biological context may need more depth. The abstract is ambiguous on this point.  
    **Why it matters** A review's utility depends on matching its presentation to its intended readership. Ambiguity here could lead to either oversimplification or excessive technicality, reducing its impact.  
    **Resolution test** Clarify in the abstract or introduction the target audience and the assumed background, and ensure the full text provides appropriate context for both biological and computational readers.

- **Minor Comments**  
  - **Concern ID** R1-m1  
    **Severity** Minor  
    **Axis** Clarity  
    **Affected element** Abstract structure  
    **Evidence pointer** Abstract text; location not provided  
    **Issue** The abstract is a single dense paragraph that lists many topics without clear logical flow or prioritization.  
    **Required correction** Restructure the abstract into distinct sections, such as background, methods covered, applications, and future outlook, to improve readability.  
  - **Concern ID** R1-m2  
    **Severity** Minor  
    **Axis** Completeness  
    **Affected element** Scope statement  
    **Evidence pointer** Abstract text; location not provided  
    **Issue** The abstract mentions "data mining" but does not define how DM differs from ML in this context, which may confuse readers.  
    **Required correction** Briefly define the relationship and distinction between ML and DM in the introduction or abstract.  
  - **Concern ID** R1-m3  
    **Severity** Minor  
    **Axis** Terminology  
    **Affected element** Use of "AI"  
    **Evidence pointer** Abstract text; location not provided  
    **Issue** The term "artificial intelligence" is used interchangeably with ML, which can be imprecise.  
    **Required correction** Use consistent terminology, defining AI as a broader field and ML as a subset, and apply this consistently throughout the text.

## Risk / unsupported claims
- The claim of providing a "thorough investigation" of ML applications is unsupported based on the abstract alone, as no depth or critical analysis is evident.
- The assertion that ML methods "unravel the fundamental mechanisms of biology" is an overstatement without concrete examples or validation.
- The abstract's coverage of specific areas, such as scRNA-seq imputation or protein structure prediction, cannot be evaluated for accuracy or completeness without the full text.
- The intended audience and level of mathematical detail are not specified, making the review's accessibility unassessable.

## Assessment against Nature-style criteria
- **Originality** The abstract does not indicate a novel framework, perspective, or synthesis that distinguishes it from existing reviews on ML in genomics. The topic is popular, and without a unique angle, originality is not evident.
- **Scientific importance** The topic is important, but the abstract does not demonstrate how this review advances understanding or practice beyond existing literature. The lack of critical synthesis weakens its potential contribution.
- **Interdisciplinary readership** The abstract spans ML, genomics, and clinical oncology, which could attract a broad audience. However, the presentation is too list-like to engage readers from different disciplines effectively.
- **Technical soundness** Not assessable from the abstract. The absence of methodological details, examples, or comparisons prevents verification of technical accuracy.
- **Readability for nonspecialists** The abstract is dense and assumes familiarity with many terms (e.g., scRNA-seq, TF binding, RBPs) without explanation. It is not accessible to a general scientific audience.

## Recommendation posture
Currently not established from the provided evidence. The abstract outlines a broad review but lacks the depth, critical evaluation, and clarity needed to assess its scientific contribution. A decision would require the full manuscript to evaluate technical accuracy, completeness, and whether the review offers new insights or a valuable synthesis. If the full text provides rigorous case studies, balanced discussion of limitations, and clear guidance for readers, the review could be supportive. As presented, the case is not made.